While reporting financial results for the second quarter on Thursday, Abbott Laboratories (ABT) reaffirmed its adjusted earnings guidance for the full-year 2023.
For fiscal 2023, the company now projects earnings in a range of $3.02 to $3.22 per share and adjusted earnings in a range of $4.30 to $4.50 per share.
Previously, the company expected earnings in the range of $3.05 to $3.25 per share and adjusted earnings in the range of $4.30 to $4.50 per share.
On average, 24 analysts polled by Thomson Reuters expect the company to report earnings of $4.40 per share for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News